Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Virendra Rambiritch, Poobalan Naidoo & Goonaseelan Pillai. (2016) Glibenclamide population pharmacokinetic/pharmacodynamic modeling in South African type 2 diabetic subjects. Clinical Pharmacology: Advances and Applications 8, pages 141-153.
Read now
Read now
Hyun-moon Back, Jong-Hwa Lee, Hwi-yeol Yun & Kwang-il Kwon. (2015) Development of QTc prolongation model incorporating circadian rhythm using harmonic model. Xenobiotica 45:5, pages 420-427.
Read now
Read now
Articles from other publishers (33)
Aydar Uatay, Louis Gall, Linda Irons, Shivendra G. Tewari, Xu (Sue) Zhu, Megan Gibbs & Holly Kimko. (2023) Physiological Indirect Response Model to Omics-Powered Quantitative Systems Pharmacology Model. Journal of Pharmaceutical Sciences.
Crossref
Crossref
Van Anh Nguyen, Li Zhang, Leonid Kagan, Malcolm Rowland & Donald E. Mager. (2023) Target Reserve and Turnover Parameters Determine Rightward Shift of Enalaprilat Potency From its Binding Affinity to the Angiotensin Converting Enzyme. Journal of Pharmaceutical Sciences.
Crossref
Crossref
Germaine Cornelissen. (2021) Applications of cosinor rhythmometry in pharmacology. Journal of Pharmacokinetics and Pharmacodynamics 48:3, pages 339-359.
Crossref
Crossref
Ranran Jia, Fan Zhang, Ni Wu, Wen Xu, Huitao Gao, Bo Liu & Hongyun Wang. (2021) Accelerating Development of Benziamidazole-Class Proton Pump Inhibitors: A Mechanism-Based PK/PD Model to Optimize Study Design with Ilaprazole as a Case Drug. Pharmaceutics 13:3, pages 392.
Crossref
Crossref
Vivaswath S. Ayyar & William J. Jusko. (2020) Transitioning from Basic toward Systems Pharmacodynamic Models: Lessons from Corticosteroids. Pharmacological Reviews 72:2, pages 414-438.
Crossref
Crossref
Vivaswath S. Ayyar, Debra C. DuBois, Toshimichi Nakamura, Richard R. Almon & William J. Jusko. (2019) Modeling Corticosteroid Pharmacokinetics and Pharmacodynamics, Part II: Sex Differences in Methylprednisolone Pharmacokinetics and Corticosterone Suppression. Journal of Pharmacology and Experimental Therapeutics 370:2, pages 327-336.
Crossref
Crossref
Ioannis Loisios-Konstantinidis, Rafael L M Paraiso, Nikoletta Fotaki, Mark McAllister, Rodrigo Cristofoletti & Jennifer Dressman. (2019) Application of the relationship between pharmacokinetics and pharmacodynamics in drug development and therapeutic equivalence: a PEARRL review. Journal of Pharmacy and Pharmacology 71:4, pages 699-723.
Crossref
Crossref
Vivaswath S. Ayyar, Wojciech Krzyzanski & William J. Jusko. (2019) Indirect pharmacodynamic models for responses with circadian removal. Journal of Pharmacokinetics and Pharmacodynamics 46:1, pages 89-101.
Crossref
Crossref
Felix Held, Carl Ekstrand, Marija Cvijovic, Johan Gabrielsson & Mats Jirstrand. (2019) Modelling of oscillatory cortisol response in horses using a Bayesian population approach for evaluation of dexamethasone suppression test protocols. Journal of Pharmacokinetics and Pharmacodynamics 46:1, pages 75-87.
Crossref
Crossref
Vivaswath S. Ayyar, Debra C. DuBois, Richard R. Almon & William J. Jusko. (2017) Mechanistic Multi—Tissue Modeling of Glucocorticoid-Induced Leucine Zipper Regulation: Integrating Circadian Gene Expression with Receptor-Mediated Corticosteroid Pharmacodynamics. Journal of Pharmacology and Experimental Therapeutics 363:1, pages 45-57.
Crossref
Crossref
Dongyang Liu, Hong Yang, Ji Jiang, Péter Nagy, Kai Shen, Jiaming Qian & Pei Hu. (2016) Pharmacokinetic and Pharmacodynamic Modeling Analysis of Intravenous Esomeprazole in Healthy Volunteers. The Journal of Clinical Pharmacology 56:7, pages 816-826.
Crossref
Crossref
C. Ekstrand, C. Ingvast-Larsson, L. Olsén, M. Hedeland, U. Bondesson & J. Gabrielsson. (2016) A quantitative approach to analysing cortisol response in the horse. Journal of Veterinary Pharmacology and Therapeutics 39:3, pages 255-263.
Crossref
Crossref
William J. Jusko. 2016. Systems Pharmacology and Pharmacodynamics. Systems Pharmacology and Pharmacodynamics
161
175
.
Leijun Hu, Yan Jin, Ying Grace Li & Anthony Borel. (2015) Population pharmacokinetic/pharmacodynamic assessment of pharmacological effect of a selective estrogen receptor β agonist on total testosterone in healthy men. Clinical Pharmacology in Drug Development 4:4, pages 305-314.
Crossref
Crossref
Vivaswath S. Ayyar, Richard R. Almon, William J. Jusko & Debra C. DuBois. (2015) Quantitative tissue-specific dynamics of in vivo GILZ mRNA expression and regulation by endogenous and exogenous glucocorticoids. Physiological Reports 3:6, pages e12382.
Crossref
Crossref
Siddharth Sukumaran, William J. Jusko, Debra C. DuBois & Richard R. Almon. (2011) Mechanistic Modeling of the Effects of Glucocorticoids and Circadian Rhythms on Adipokine Expression. Journal of Pharmacology and Experimental Therapeutics 337:3, pages 734-746.
Crossref
Crossref
Xu Steven Xu, Hui Wang & An Vermeulen. (2011) Modeling delayed drug effect using discrete-time nonlinear autoregressive models: a connection with indirect response models. Journal of Pharmacokinetics and Pharmacodynamics 38:3, pages 353-367.
Crossref
Crossref
K T Luu, S R Raber, D J Nickens & P Vicini. (2010) A Model-Based Meta-Analysis of the Effect of Latanoprost Chronotherapy on the Circadian Intraocular Pressure of Patients With Glaucoma or Ocular Hypertension. Clinical Pharmacology & Therapeutics 87:4, pages 421-425.
Crossref
Crossref
Takahiko Aoyama, Takayuki Omori, Satoshi Watabe, Akemi Shioya, Takahiro Ueno, Noboru Fukuda & Yoshiaki Matsumoto. (2010) Pharmacokinetic/Pharmacodynamic Modeling and Simulation of Rosuvastatin Using an Extension of the Indirect Response Model by Incorporating a Circadian Rhythm. Biological and Pharmaceutical Bulletin 33:6, pages 1082-1087.
Crossref
Crossref
Sukyung Woo, Dipti Pawaskar & William J. Jusko. (2009) Methods of utilizing baseline values for indirect response models. Journal of Pharmacokinetics and Pharmacodynamics 36:5, pages 381-405.
Crossref
Crossref
Bi‐Botti C. Youan. 2009. Chronopharmaceutics. Chronopharmaceutics
1
49
.
Bruce Charles, Yvan Touitou & Brahim Selmaoui. (2009) A population Pharmacokinetic Turnover and Surge‐Function Model for Describing Melatonin Biological Rhythm in Healthy Male Subjects. Journal of Pharmaceutical Sciences 98:2, pages 782-790.
Crossref
Crossref
Jin Y. Jin & William J. Jusko. (2009) Pharmacodynamics of glucose regulation by methylprednisolone. II. normal rats. Biopharmaceutics & Drug Disposition 30:1, pages 35-48.
Crossref
Crossref
Y Hong, J Dingemanse & DE Mager. (2008) Pharmacokinetic/Pharmacodynamic Modeling of Renin Biomarkers in Subjects Treated With the Renin Inhibitor Aliskiren. Clinical Pharmacology & Therapeutics 84:1, pages 136-143.
Crossref
Crossref
Anasuya Hazra, Nancy A. Pyszczynski, Debra C. DuBois, Richard R. Almon & William J. Jusko. (2007) Modeling of Corticosteroid Effects on Hepatic Low-Density Lipoprotein Receptors and Plasma Lipid Dynamics in Rats. Pharmaceutical Research 25:4, pages 769-780.
Crossref
Crossref
Anna Lönnebo, Anders Grahnén & Mats O. Karlsson. (2007) An integrated model for the effect of budesonide on ACTH and cortisol in healthy volunteers. British Journal of Clinical Pharmacology 64:2, pages 125-132.
Crossref
Crossref
Ying Hong, Donald E. Mager, Robert A. Blum & William J. Jusko. (2007) Population Pharmacokinetic/Pharmacodynamic Modeling of Systemic Corticosteroid Inhibition of Whole Blood Lymphocytes: Modeling Interoccasion Pharmacodynamic Variability. Pharmaceutical Research 24:6, pages 1088-1097.
Crossref
Crossref
Donald E. Mager & Darrell R. Abernethy. (2007) Use of Wavelet and Fast Fourier Transforms in Pharmacodynamics. Journal of Pharmacology and Experimental Therapeutics 321:2, pages 423-430.
Crossref
Crossref
Yuen Yi Hon, William J. Jusko, Vicky E. Spratlin & Michael W. Jann. (2006)
Altered Methylprednisolone Pharmacodynamics in Healthy Subjects With
Histamine N-Methyltransferase
C314T Genetic Polymorphism
. The Journal of Clinical Pharmacology 46:4, pages 408-417.
Crossref
Crossref
Donald E. Mager, Sheren X. Lin, Robert A. Blum, Christian D. Lates & William J. Jusko. (2013) Dose Equivalency Evaluation of Major Corticosteroids: Pharmacokinetics and Cell Trafficking and Cortisol Dynamics. The Journal of Clinical Pharmacology 43:11, pages 1216-1227.
Crossref
Crossref
Honghui Zhou. 2002. Pharmacokinetics in Drug Discovery and Development. Pharmacokinetics in Drug Discovery and Development.
Mindy He Magee, Robert A. Blum, Christian D. Lates & William J. Jusko. (2013) Prednisolone Pharmacokinetics and Pharmacodynamics in Relation to Sex and Race. The Journal of Clinical Pharmacology 41:11, pages 1180-1194.
Crossref
Crossref
Thomas A. Puchalski, Wojciech Krzyzanski, Robert A. Blum & William J. Jusko. (2013) Pharmacodynamic Modeling of Lansoprazole Using an Indirect Irreversible Response Model. The Journal of Clinical Pharmacology 41:3, pages 251-258.
Crossref
Crossref